Science & Enterprise subscription

Please share Science & Enterprise

RSS
Follow by Email
Facebook
Facebook
Google+
Twitter
Visit Us
LinkedIn

Donate to our blog

Your support will help Science & Enterprise continue to provide science news for business people and business news for scientists.

Affiliations

Science Blogs
ACI Profile for Alan Kotok
Featured in Alltop

Enhanced Gene Therapy Boosts Anti-Tumor Response

Gene therapies delivered with electronic pulses were shown in lab mice to increase production of natural immune-system proteins and reduce melanoma, or advanced skin cancer, tumors. . . . → Read More: Enhanced Gene Therapy Boosts Anti-Tumor Response

CARB-X Commits $48M for Antibiotic Resistance R&D

A public-private partnership is spending $48 million in grants to biotechnology companies for research on treatments and diagnostics to counter antibiotic resistance, with half of that amount distributed immediately. . . . → Read More: CARB-X Commits $48M for Antibiotic Resistance R&D

Diet Enhancing Gut Microbes Shown to Slow Type 1 Diabetes

A diet that produces certain short-chain fatty acids in the gut is shown in lab mice to support the immune system and slow the onset of type 1 diabetes. . . . → Read More: Diet Enhancing Gut Microbes Shown to Slow Type 1 Diabetes

Trials, Registry Planned for Wound Care Device

A company making products for healing wounds is studying the ways one of its dressings is used in the field, to better understand the product’s role in wound care. . . . → Read More: Trials, Registry Planned for Wound Care Device

Protein IDed to Cut Implanted Device Immune Reactions

Researchers at MIT identified a protein playing a key role in promoting the scar tissue that forms from immune reactions to implanted medical devices, and blocking actions of this protein can prevent scar tissue from forming on materials often used with implants. . . . → Read More: Protein IDed to Cut Implanted Device Immune Reactions

Organ Transplant Start-Up Gains $38M in Early Funds

A one year-old company applying genome editing to make animal organs fit for human transplantation is raising $38 million its first venture funding round. . . . → Read More: Organ Transplant Start-Up Gains $38M in Early Funds

Nanotech Gel Designed to Treat Snake Bites

A team from University of California in Irvine developed a snake bite treatment that in lab tests stops venom more effectively and at lower cost than current antidotes. . . . → Read More: Nanotech Gel Designed to Treat Snake Bites

Trial Underway to Test Cancer Immunotherapy Aid

A clinical trial began recruiting participants with advanced tumors to test a compound that helps treatments for cancer harnessing the immune system. . . . → Read More: Trial Underway to Test Cancer Immunotherapy Aid

Messenger RNA Engineered to Produce Antibodies

Academic and industry researchers demonstrated production of therapeutic antibodies inside cells of lab mice, offering a simpler and lower-cost alternative to monoclonal antibodies. . . . → Read More: Messenger RNA Engineered to Produce Antibodies

Biotech Companies to Discover Ebola, Zika Vaccines

Two biotechnology companies are collaborating to discover new vaccines protecting against Ebola and Zika viruses that present global threats to public health. . . . → Read More: Biotech Companies to Discover Ebola, Zika Vaccines